Table 4.
Relationship between plasma CD4 + and CD3+ distribution and anti‐HER2 benefit
CD3+ | CD4+ | |||||||
---|---|---|---|---|---|---|---|---|
Upper | Lower | Z | P | Upper | Lower | Z | P | |
PFS(m) | 9 | 12 | −1.639 | 0.101 | 8 | 12 | −1.693 | 0.091 |
OS(m) | 20 | 23 | −0.797 | 0.327 | 15 | 24.5 | −1.950 | 0.051 |
PFS: progression‐free survival; OS: overall survival. PFS and OS are displayed with the median of survival time. Mann‐Whitney U test was conducted to detect differences in survival time between the two subgroups.